Navigation Links
Senn Chemicals Appoints New Chief Executive Officer
Date:9/4/2013

Dielsdorf, Switzerland (PRWEB) September 04, 2013

Today, Senn Chemicals announced the appointment of Dr. Thomas Eisele as their new Chief Executive Officer. Dr. Eisele was previously with CarboGen-Amcis, Novasep-Rohner and Synphabase, and most recently at Hovione, where he held the position of Vice President, Corporate R&D.

Interim CEO, Carlo Haechler, will actively guide the transition while remaining as the functional chief executive until 30 September 2013. After which time, Dr. Eisele will take the helm and Mr. Haechler will remain in an advisory role to Senn Chemicals.

“We are delighted to welcome Dr. Eisele to the Senn team,” commented Senn Chairman of the Board, Christoph Schmid. “He provides us with a robust combination of broad scientific acumen and market savvy, which will be essential to our successful expansion plans both in terms of production capacity and global market reach.”

"I am excited and honoured about this new opportunity to lead the Senn Chemicals team in Switzerland. Throughout my career I have had a great respect for Senn, a company that is recognized as a world leader in peptide manufacturing. I am looking forward to helping further enhance Senn´s established reputation for offering tailor made solutions for our partners and to develop a successful company into a premier global player providing integrated solutions for any molecule," said Dr. Eisele.

Dr. Eisele is trained as an organic chemist at the University of Constance, Germany and holds a PhD from the same university. He brings over 16 years of experience in the development and scale-up of APIs from lead candidate optimization through NDA submission and commercialization. Dr. Eisele is intimately familiar with CRO and CMO operations and related quality requirements. Moreover, his business development and broad reaching staff management responsibilities provide him with the ideal experience base to lead the growing company to new levels of success.

ABOUT SENN CHEMICALS
Senn is a contract manufacturing organization specializing in custom synthesis of peptides and related compounds for use as active pharmaceutical ingredients and intermediates. Based in Dielsdorf, Switzerland, Senn has provided full service CMO support for biotechnology and pharmaceutical organizations worldwide since 1963.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11083082.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Global Crop Protection Chemicals Market Till 2016 - Worldwide Research Report, Industry Share, Size, Trends, Analysis, Growth and Forecast 2012-2016: MarketResearchReports
2. Environmental Concerns & Depleting Fossil Fuels Drive the Global Renewable Chemicals Market, According to New Report by Global Industry Analysts, Inc.
3. DuPont Realigns Leadership Team to Accelerate Integrated Science Execution, Explores Strategic Alternatives for Performance Chemicals
4. UPM Signs Joint Development Agreement with Renmatix in Biochemicals
5. Lucintel Report Outlines $821.8 Billion Market for Global Basic Petrochemicals Industry by 2018
6. Steps for Getting Rid of Bed Bugs without Using Chemicals and Avoiding Them While Traveling Enumerated by My Cleaning Products in Its Latest Post
7. Held Up Mold Problem Gets Staten Island Residents Parading for City's Help, Tip How to Kill Mold Without Use of Harmful Chemicals Offered by My Cleaning Products
8. Bed Bugs Bum Rides on Taxis, Use of Non-Pesticide Bed Bug Spray Recommended by My Cleaning Products to Kill the Pests Without Strong Chemicals' Help
9. Probiotic Action Shares Insight for Parents on How to Treat Pre-Teen Acne without Chemicals
10. Non-Invasive Rust Remover Clears Rust Without Use of Chemicals, My Cleaning Products Dishes Out Samples of It to Prove It Works
11. Piedmont Chemical Launches 100 Percent Renewable Polyester Polyols Leveraging Renewable Chemicals from DuPont Tate & Lyle Bio Products and Myriant Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... Ca (PRWEB) , ... August 16, 2017 , ... ... by changing into a different cell type. Many treatments for specific cancers, such ... prominent example of targeted treatment is androgen deprivation therapy for advanced prostate cancer. ...
(Date:8/16/2017)... , Aug. 16, 2017  This year,s edition of the Inc. ... in life sciences workforce solutions, has made the list for the third ... recognizes the nation,s fastest-growing private companies based on a set of quantitative ... which includes the fastest-growing companies in the Bay State ... Inc. 5000 ...
(Date:8/15/2017)... ... August 15, 2017 , ... Nanomedical ... and biotherapeutics development, announces the launch of the new NHS Agile biosensor ... kinetic binding data for a wide range of molecules, including small and large ...
(Date:8/15/2017)... ... August 15, 2017 , ... The Conference Forum and The ... through a series of upcoming panels and events. The partnership culminates with the ... Hotel in New York City. , “With our experience in producing the Immuno-Oncology 360° ...
Breaking Biology Technology:
(Date:4/5/2017)... 2017  The Allen Institute for Cell Science today ... one-of-a-kind portal and dynamic digital window into the human ... first application of deep learning to create predictive models ... and a growing suite of powerful tools. The Allen ... future publicly available resources created and shared by the ...
(Date:4/4/2017)... April 4, 2017   EyeLock LLC , a ... the United States Patent and Trademark Office (USPTO) has ... the linking of an iris image with a face ... represents the company,s 45 th issued patent. ... very timely given the multi-modal biometric capabilities that have ...
(Date:3/30/2017)... , March 30, 2017 The research ... system for three-dimensional (3D) fingerprint identification by adopting ground breaking 3D ... a new realm of speed and accuracy for use in identification, ... an affordable cost. ... ...
Breaking Biology News(10 mins):